Alan Wells Selected Research

1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dione

7/2008	Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.
9/2003	Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan Wells Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 01/2002
24	Wounds and Injuries (Trauma) 01/2022 - 01/2002
20	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2003
19	Breast Neoplasms (Breast Cancer) 10/2021 - 07/2003
17	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2002
16	Carcinoma (Carcinomatosis) 12/2019 - 01/2002
13	COVID-19 01/2022 - 06/2020
10	Cicatrix (Scar) 01/2022 - 12/2006
6	Neoplasm Micrometastasis 01/2022 - 01/2008
6	Melanoma (Melanoma, Malignant) 01/2021 - 07/2010
5	Inflammation (Inflammations) 01/2021 - 01/2012
4	Squamous Cell Carcinoma of Head and Neck 07/2008 - 09/2003
3	Starvation 01/2018 - 01/2008
2	HIV Infections (HIV Infection) 01/2022 - 01/2022
2	Triple Negative Breast Neoplasms 10/2021 - 06/2012
2	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 04/2021
2	Blister (Bulla) 01/2021 - 10/2020
2	Fibrosis (Cirrhosis) 01/2021 - 05/2011
2	Glaucoma 01/2021 - 10/2020
2	Schizophrenia (Dementia Praecox) 01/2020 - 10/2018
2	Neurodevelopmental Disorders 01/2020 - 10/2018
2	Autism Spectrum Disorder 01/2020 - 10/2018
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2019 - 01/2010
2	Infections 11/2017 - 10/2017
2	Glioblastoma (Glioblastoma Multiforme) 10/2008 - 01/2002
2	Keloid 07/2006 - 03/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022

Drug/Important Bio-Agent (IBA)

18	Cadherins (E-Cadherin)IBA 01/2022 - 01/2008
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2003
14	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2002
13	CollagenIBA 01/2022 - 09/2003
11	CytokinesIBA 01/2022 - 03/2005
10	Epidermal Growth Factor (EGF)IBA 01/2021 - 08/2003
9	LigandsIBA 01/2021 - 09/2003
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 12/2014
7	matrigelIBA 01/2013 - 06/2002
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012 - 01/2002
6	ChemokinesIBA 01/2022 - 01/2002
6	CalpainIBA 03/2011 - 01/2002
5	Atorvastatin (Lipitor)FDA Link 10/2021 - 01/2018
5	Messenger RNA (mRNA)IBA 08/2021 - 01/2008
5	TenascinIBA 01/2017 - 01/2013
5	Biological ProductsIBA 01/2017 - 07/2003
4	Monoclonal AntibodiesIBA 01/2022 - 05/2021
4	Protein Isoforms (Isoforms)IBA 10/2021 - 01/2012
4	Pharmaceutical PreparationsIBA 10/2020 - 01/2003
4	CholesterolIBA 11/2018 - 12/2014
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2016 - 03/2004
3	VaccinesIBA 01/2022 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2003
3	DecorinIBA 01/2022 - 12/2006
3	Mevalonic Acid (Mevalonate)IBA 01/2021 - 12/2014
3	Indicators and Reagents (Reagents)IBA 10/2018 - 01/2003
3	EnzymesIBA 06/2018 - 01/2002
3	Small Interfering RNA (siRNA)IBA 01/2018 - 11/2012
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
3	Hormones (Hormone)IBA 01/2018 - 04/2002
3	CXC ChemokinesIBA 07/2015 - 06/2003
3	Phosphotransferases (Kinase)IBA 04/2014 - 09/2005
2	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2012
2	Oxygen (Dioxygen)IBA 01/2022 - 05/2021
2	casirivimab and imdevimab drug combinationIBA 01/2022 - 01/2022
2	mRNA VaccinesIBA 07/2021 - 04/2021
2	AntibodiesIBA 04/2021 - 01/2021
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021 - 10/2020
2	InflammasomesIBA 01/2021 - 10/2017
2	Neutralizing AntibodiesIBA 11/2020 - 06/2020
2	FurinIBA 11/2020 - 06/2020
2	Extracellular Matrix ProteinsIBA 01/2020 - 07/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2019 - 07/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 06/2012
2	LipidsIBA 01/2018 - 01/2018
2	Microfilament Proteins (Actin Binding Proteins)IBA 01/2018 - 02/2009
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 12/2016
2	PolymersIBA 01/2017 - 09/2007
2	AndrogensIBA 01/2017 - 04/2002
2	Protein Kinases (Protein Kinase)IBA 11/2016 - 05/2006
2	Janus KinasesIBA 11/2016 - 06/2005
2	PlatinumIBA 07/2015 - 01/2003
2	Fibronectins (Fibronectin)IBA 09/2013 - 07/2006
2	4- ((3- bromophenyl)amino)- 6,7- dimethoxyquinazolineIBA 11/2012 - 01/2012
2	VimentinIBA 04/2012 - 02/2010
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2012 - 04/2002
2	Peptide Hydrolases (Proteases)FDA Link 03/2011 - 10/2008
2	CXCR3 ReceptorsIBA 04/2010 - 09/2008
2	Profilins (Profilin)IBA 05/2009 - 02/2009
2	Chemokine ReceptorsIBA 01/2009 - 09/2005
2	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 07/2008 - 09/2003
2	Phospholipase C gammaIBA 07/2008 - 03/2004
2	Growth Factor ReceptorsIBA 05/2006 - 01/2002
2	Phospholipases (Phospholipase)IBA 09/2003 - 01/2003

Therapy/Procedure

23	Therapeutics 01/2022 - 01/2003
11	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
2	Immunotherapy 01/2022 - 10/2020
2	Filtering Surgery 01/2021 - 10/2020
2	Trabeculectomy (Trabeculoplasty) 01/2021 - 10/2020
2	Bioreactors (Bioreactor) 01/2013 - 01/2007
1	Castration 01/2022